Are Wall Street Analysts Bullish on Kimberly-Clark Stock?
🏢 Kimberly-Clark Corporation (KMB) operates in the personal care sector with products including diapers, wipes, and feminine care, holding a $32.1 billion market cap.
📉 KMB shares have underperformed the broader S&P 500 Index over the past year, declining 29.5% while the index surged 27.3%.
📊 In 2026 to date, the stock has fallen nearly 4%, contrasting with the SPX’s 9.6% rise, and it also lagged the XLP ETF which rose 4.9%.
💹 KMB reported Q1 2026 earnings where revenue grew 2.7% year-over-year to $4.2 billion, surpassing analyst estimates.
✅ Adjusted EPS for Q1 2026 came in at $1.97, exceeding Wall Street forecasts after four consecutive quarters of beating consensus.
📅 For the fiscal year ending December, analysts expect diluted EPS to decline marginally to $7.48.
👥 The consensus rating among 16 analysts covering KMB is a "Moderate Buy," comprised of ratings ranging from Strong Buy to Strong Sell.
🎯 UBS analyst Peter Grom recently maintained a "Hold" rating but lowered the price target from $110 to $105 on April 7.
🔮 The mean price target of $114.62 suggests a 19% premium from current market prices according to analysts.
⬆️ The Street-high price target of $162 implies a potential 68.2% upside from current trading levels.
- Kimberly-Clark's Q1 2026 revenue grew 2.7% year-over-year to $4.2 billion, successfully surpassing Wall Street estimates.
- The company reported adjusted EPS of $1.97 for the quarter, which also exceeded analyst forecasts.
- KMB has surpassed the consensus EPS estimate in each of the last four consecutive quarters, demonstrating consistent performance.
- Among 16 analysts covering the stock, there are four 'Strong Buy' ratings and one 'Moderate Buy' rating supporting a 'Moderate Buy' consensus.
- The average price target of $114.62 suggests significant upside potential relative to current market prices.
- KMB shares have significantly lagged the broader market, declining 29.5% over the past year compared to the S&P 500's 27.3% surge.
- As of 2026, the stock has fallen nearly 4%, underperforming the SPX's 9.6% rise.
- The industry benchmark ETF (XLP) has outperformed the stock, rising 4.9% over the past year and 9.6% in 2026.
- Analysts expect KMB's EPS to decline marginally to $7.48 for the current fiscal year, breaking its streak of beating estimates in four consecutive quarters.
- The consensus analyst rating is a 'Moderate Buy', with only one 'Strong Sell' and ten 'Holds' among the 16 analysts covering the stock.
- UBS analyst Peter Grom lowered the price target from $110 to $105, maintaining a cautious 'Hold' rating despite a mean target still showing 19% upside.